Page last updated: 2024-11-05

trifluoperazine and Myocarditis

trifluoperazine has been researched along with Myocarditis in 2 studies

Myocarditis: Inflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the cardiac muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden death (DEATH, SUDDEN). Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goren, N1
Leiros, CP1
Sterin-Borda, L1
Borda, E1
Jaffe, CM1

Other Studies

2 other studies available for trifluoperazine and Myocarditis

ArticleYear
Nitric oxide synthase in experimental autoimmune myocarditis dysfunction.
    Journal of molecular and cellular cardiology, 1998, Volume: 30, Issue:11

    Topics: Animals; Anti-Inflammatory Agents; Antibodies, Monoclonal; Autoimmune Diseases; Dexamethasone; Enzym

1998
First-degree atrioventricular block during lithium carbonate treatment.
    The American journal of psychiatry, 1977, Volume: 134, Issue:1

    Topics: Adult; Bipolar Disorder; Electrocardiography; Female; Heart Block; Humans; Lithium; Myocarditis; Tri

1977